CMV pp86 Antibodies

Santa Cruz Biotechnology offers a broad range of CMV pp86 Antibodies for understanding the role of the cytomegalovirus (CMV) protein pp86. CMV pp86 Antibodies are validated for various techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CMV pp86 protein is crucial for viral replication and plays a significant role in the immune evasion strategies of the virus. Research focused on CMV pp86 can provide valuable insights into CMV pathogenesis and its impact on human health, particularly in immunocompromised individuals. Understanding the function of CMV pp86 is essential for developing therapeutic strategies against CMV infections. Investigating CMV pp86 can reveal important mechanisms of viral infection and host immune responses. Exploring the molecular interactions of CMV pp86 helps advance our understanding of viral persistence and immune modulation. Santa Cruz Biotechnology monoclonal antibodies for CMV pp86 enable researchers to make meaningful contributions to virology and infectious disease research.